Mirroring the obesity pandemic, nonalcoholic fatty liver disease (NAFLD) has become the most common liver disease affecting populations worldwide. Approximately 30% of the adult United States (US) population is estimated… Click to show full abstract
Mirroring the obesity pandemic, nonalcoholic fatty liver disease (NAFLD) has become the most common liver disease affecting populations worldwide. Approximately 30% of the adult United States (US) population is estimated to be afflicted with NAFLD. NAFLD is a spectrum of liver disease ranging from nonalcoholic fatty liver (NAFL), the non-progressive sub-type, to nonalcoholic steatohepatitis (NASH), the progressive sub-type, which can lead to progressive liver disease leading to cirrhosis and hepatocellular carcinoma(1).
               
Click one of the above tabs to view related content.